FDA clears Histofluor slides

Histofluor Rodent Tissue Slides receive FDA 510(k) clearance
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
SACRAMENTO, Calif.—Immuno Concepts, a recognized pioneer in innovation of autoimmune diagnostic reagents and instrumentation, is pleased to announce that the United States Food and Drug Administration (FDA), through the 510(k) process, has cleared the Histofluor Rodent LKS Tissue Slides for manual and Image Navigator use.
Continue reading below...
A 3D illustration of pink-colored immune cells with blue cell markers on their surfaces floating in a pink background
WebinarsUncovering biomarkers in inflammatory disease ​
Combining advanced single cell multiomics tools helps researchers reveal hidden triggers of inflammatory skin conditions.
Read More
The indirect immunofluorescent (IIF) test has long been the preferred method for determination of Anti-Mitochondrial Antibodies, Anti-Smooth Muscle Antibodies, and Anti-Parietal Cell Antibodies. These autoantibodies are associated with several autoimmune diseases, including Pernicious Anemia or Autoimmune Gastritis, Primary Biliary Cholangitis, and Autoimmune Hepatitis. The FDA-cleared Immuno Concepts’ Histofluor Rodent Tissue Slides are available in both mouse and rat substrates and can be read manually or scanned using the innovative Image Navigator automated microscope.
The same slides and reagents for the Histofluor Rodent Tissue Slides are used regardless of whether the slides are read manually or scanned on the Image Navigator. There are no other ingredients or special conditions required. The previously FDA-cleared Image Navigator is a solution that eliminates the usual tedious labor of the IIF test, while still allowing the laboratory professional to control the interpretation and reporting of these tests.
“The new Histofluor Rodent LKS Fluorescent Antibody Test System improves on a diagnostic technique that dates back several decades. The Immuno Concepts kits do not require freezing of any component, including the tissue slides. The available positive controls and titratable controls provide assurance to the user that the patterns seen on the tissues are true evidence of the corresponding autoantibodies,” commented Eric S. Hoy, Ph.D., SI(ASCP), Chief Scientific Officer of Immuno Concepts.
“All of the components are ready-to-use and are identical whether the user runs the assay manually or on the Image Navigator. The Image Navigator captures multiple images of the three rodent tissues and assembles them into a panoramic view of the well. The user can apply the standard features of the Image Navigator to enlarge regions of the tissue to examine fine detail and determine the antibody specificity of the fluorescent staining. The new slides and the Image Navigator together eliminate much of the subjectivity formerly associated with this testing.”
In 1979, Immuno Concepts pioneered the industry conversion from rodent tissue to HEp-2 cells for detection of ANAs. Immuno Concepts followed up with HEp-2000, the only patented ANA substrate genetically enhanced to improve sensitivity for detection of autoantibodies to the SS-A/Ro antigen. Today, Immuno Concepts has the automated solution for IFA assays, the Image Navigator. Together the family of AFT pipetting instruments and Image Navigator can process a patient sample from collection tube to final result, with reportedly better reproducibility and accuracy than manual methods.

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D molecular visualization of antibody-like protein structures with attached yellow payloads floating against a dark, space-like background.
Evolving approaches to conjugation chemistry and linker–payload design are helping address persistent challenges in bioconjugate development.
Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue